A 63-year-old man was admitted to our hematology department with extensive nodular lesions on the trunk, submental area, forehead, scalp and a plaque extending over the right shoulder. Four months before admission to our department, he had been examined for swellings on the left side of his face and the right shoulder. On physical examination, a firm, 4-cm mass inferior to the left zygomatic arch, a 15-cm brown pigmented, indurated mass extending from the lateral side of sternocleidomastoid region to the deltoid muscle and multiple submandibular lympadenopathies measuring a maximum diameter of 3.5 cm were noted. At that time, his laboratory parameters were normal, including a complete blood count and blood chemistries. MRI scan of the face revealed a 4.2 × 2.3 × 3.8-cm slightly lobulated mass at the inferior of the left zygomatic arch, extending from the nasolabial sulcus to the mandibular corpus and the lateral maxilla. Also, multiple lymphadenopathies with a maximal diameter of 3.4 cm were present at the submandibular, jugulodigastric regions and the posterior spinal accessory chain. A 15 × 10-cm mass on the right shoulder joint extending from the lateral side of sternocleidomastoid region to the deltoid muscle was evident on MRI. A skin biopsy had been obtained from the plaque lesion on the right shoulder. One month after the skin biopsy, the patient was evaluated for worsening malaise and fatigue. The laboratory results were as follows: leukocyte 46,000/mm3 (monocyte 44%, neutrophil 39%), hemoglobin 9 g/dl, platelet 64,000/mm3, LDH 1,109 IU/l (normal range, 240–480 IU/l). The skin biopsy of the plaque lesion showed diffuse neoplastic infiltration with positivity for myeloperoxidase (MPO) and CD34 on immunohistochemical staining. On peripheral blood smear, diffuse myeloblastic infiltration was evident (fig. ). The bone marrow aspirate was hypercellular, with 22% monocytoid blasts. Immunophenotypic analysis of peripheral blood was positive for CD13, CD15, CD25, CD33, CD34, CD45, HLA-DR and MPO. These findings were compatible with acute monocytic leukemia (FAB AML-M5b). Having presented with skin involvement one month prior to the onset of AML-M5b, the final diagnosis was ALC. The remission induction regimen consisted of cytarabine 100 mg/m2 daily on days 1–7 and daunorubicin 60 mg/m2 daily on days 1–3. On the 2nd week of chemotherapy, febrile neutropenia developed. Imipenem-susceptible Pseudomonas aeruginosa was grown on culture media. After seven days of persistent fever under imipenem, empirical antifungal treatment with amphotericin-B was added and was subsequently substituted by voricanozole four days later due to ongoing fever. On day 28, there were no myeloblasts on peripheral blood smear and bone marrow examination, but there was only 50% regression of skin lesions. Therefore, the same chemotherapy regimen was administered for reinduction. On day 28 of reinduction, physical examination revealed hepatosplenomegaly, extensive brown pigmented nodular lesions on the trunk, submental area, forehead, scalp and a plaque extending over the right shoulder. Then, the patient was referred to our hematology department. The reexamination of the previous skin biopsy specimen revealed diffuse neoplastic infiltration extending from the dermis to subcutaneous tissue with diffuse positivity for MPO and focal positivity for CD34 on immunohistochemical staining, which were findings compatible with the diagnosis of LC (fig. ). On his physical examination at our clinic, progressive skin infiltrations as nodular eruptions on scalp, forehead and trunk and a plaque on the right shoulder were noted (fig. ). At the time of admission, the laboratory results were as follows: leukocyte 2,000/mm3 (monocyte 42%, neutrophil 32%), hemoglobin 8 g/dl, platelet 76,000/mm3, serum LDH 1,335 IU/l and ESR 96 mm/h. The bone marrow aspirate showed 20% blastic infiltration. Histopathologic examination disclosed a hypercellular marrow with a medium to diffuse increase in reticulin fibers and 20% immature cells staining positive for MPO, CD33, CD34. Diagnosed as refractory disease, FLAG chemotherapy, a more aggressive regimen consisting of granulocyte colony-stimulating factor, a 5-day course of 30 mg/m2/day fludarabine and 2 g/m2/day cytosine arabinoside was initiated. On the 8th day of chemotherapy, neutropenia developed. Subsequently, urinary tract infection caused by enterococci was diagnosed and treated with piperacillin/tazobactam for 14 days. On the 10th day of induction chemotherapy, the nodular lesion on the face almost completely regressed, the pigmentation of nodular lesions on the trunk began to fade, and the indurated plaque on the right shoulder healed with hyperpigmentation (fig. ). On the 23rd day of chemotherapy, the patient developed neutropenic fever. Escherichia coli was isolated on blood culture and imipenem was started. Later, ampiric antifungal treatment with amphotericin-B was added because of ongoing fever. However, amphotericin-B was substituted for caspofungin for allergic reaction. On the 28th day of chemotherapy, LDH returned to normal and the skin infiltrates largely disappeared. However, on the 45th day of chemotherapy, new disseminated nodular eruptions reappeared on the forehead, face and trunk. In addition, a 5-cm firm, endurated nodular lesion at the left submental area, a 1-cm mass at the left nasal cavity and a 15 × 10-cm mass on the right shoulder joint extending from the lateral side of sternocleidomastoid region to the deltoid muscle were detected. There was considerable venous distention of the right arm due to the occlusion of the right subclavian vein confirmed by venous Doppler USG (fig. ). The blood count was as follows: leukocyte 4,730/mm3 (monocyte 73%, neutrophil 17%), hemoglobin 7 g/dl, and platelet 24,000/mm3. Peripheral blood smear revealed 92% myeloblasts. Serum LDH was 1,466 IU/l. Emergent chemotherapy to relieve pressure symptoms was initiated with cytarabine 100 mg/m2 for 7 days and idarubicin 12 mg/m2 for 3 days. On the 7th day of chemotherapy, febrile neutropenia was diagnosed. The blood culture was positive for Pseudomonas aeruginosa. Meropenem and ciprofloxacin were started. After 14 days, trimethoprim-sulphonamide was added for ongoing fever. On the 28th day of chemotherapy, all the skin lesions except for those on the trunk showed significant clinical improvement. The distention of the right arm disappeared. The patient had prolonged neutropenia for 3 months. The patient succumbed to his disease 6 months after initial diagnosis.
Peripheral smear with atypical monocytoid cells (FAB AML-M5b).
Fig. 2 a The skin biopsy specimen of the plaque lesion showed diffuse neoplastic infiltration in the dermis and subcutis (H&E, ×400). Immunohistochemical features. The infiltrated cells were diffuse positive for MPO (b; ×400) and focally (more ...)
Fig. 3 a–c The appearance of the lesions at admission to our center after two courses of remission induction with cytarabine and daunorubicin. Nodular eruptions on the forehead (a), trunk (b) and a plaque lesion extending over the right shoulder (c). (more ...)
The distended right forearm due to the occlusion of the right subclavian vein by the mass on the right shoulder.